MRNA

Moderna Inc

254.33

Nov 11 • 8:46 AM ET +3.50 (1.40%)

Healthcare Biotechnology USA Large NASD

Nov 09, 12:04 PMPiper Sandler’s $305 target helps lift Moderna 10% as post-earnings rally extends

Peers: BNTX NVAX PCVX ALNY ARCT REGN VALN IONS VIR MRVI

| Held by: QQQ VTI VOO IVV SPY VB IBB VO XLV CGGR

Scroll to Statements

Index	NDX, S&P 500, RUI
Market Cap	102.91B
Enterprise Value	101.97B
Income	-2.79B
Sales	2.52B
Book/sh	16.92
Cash/sh	12.78
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	4700
IPO	Dec 07, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	40.76
P/B	15.03
P/C	19.90
P/FCF	-
EV/EBITDA	-
EV/Sales	40.38
Quick Ratio	3.47
Current Ratio	3.62
Debt/Eq	0.62
LT Debt/Eq	0.61
Option/Short	Yes / Yes

EPS (ttm)	-7.09
EPS next Y	-4.36
EPS next Q	-2.01
EPS this Y	-6.80%
EPS next Y	43.78%
EPS next 5Y	31.24%
EPS past 3/5Y	- -29.93%
Sales past 3/5Y	-53.32% 19.33%
EPS Y/Y TTM	12.35%
Sales Y/Y TTM	13.13%
EPS Q/Q	173.93%
Sales Q/Q	29.23%
Earnings	Nov 06 BMO
EPS/Sales Surpr.	134.68% 47.49%

Insider Own	8.52%
Insider Trans	-2.46%
Inst Own	77.47%
Inst Trans	2.46%
ROA	-21.79%
ROE	-34.50%
ROIC	-25.32%
Gross Margin	17.82%
Oper. Margin	-116.04%
Profit Margin	-110.46%
SMA20	10.22%
SMA50	28.01%
SMA200	168.77%
Trades

Shs Outstand	404.00M
Shs Float	370.13M
Short Float	8.97%
Short Ratio	1.53
Short Interest	33.19M
52W High	280.80 -9.43%
52W Low	22.28 1041.52%
Volatility	10.90% 10.84%
ATR (14)	20.41
RSI (14)	60.58
Beta	1.15
Rel Volume	0.14
Avg Volume	21.76M
Volume	153,078

Perf Week	-1.57%
Perf Month	17.61%
Perf Quarter	299.58%
Perf Half Y	404.42%
Perf YTD	762.43%
Perf Year	863.01%
Perf 3Y	263.07%
Perf 5Y	12.63%
Perf 10Y	-
Recom	3.07
Target Price	155.95
Prev Close	250.83
Price	254.33
Change %	1.40%

Consensus

Hold

Avg. Price Target

$155.95

Implied Upside

-38.7%

Analysts14incl. previous ratings

Rating Distribution2 Buy · 10 Hold · 2 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Oct 27, 2026	Downgrade	WWilliam Blair	Outperform → Mkt Perform
Sep 30, 2026	Downgrade	CCitigroup	Neutral → Sell	$80	-68.5%
Sep 03, 2026	Downgrade	RRothschild & Co Redburn	Neutral → Sell	$81	-68.2%
Aug 28, 2026	Upgrade	AArgus	Hold → Buy	$180	-29.2%
Aug 25, 2026	Upgrade	WWolfe Research	Underperform → Peer Perform
Aug 19, 2026	Upgrade	WWilliam Blair	Mkt Perform → Outperform
Aug 19, 2026	Upgrade	BBofA Securities	Underperform → Neutral
Jan 28, 2026	Resumed	BBarclays	Equal Weight	$25	-90.2%
Jan 07, 2026	Resumed	UUBS	Neutral	$34	-86.6%
Dec 12, 2025	Initiated	JJefferies	Hold	$30	-88.2%
Mar 13, 2025	Initiated	CCitigroup	Neutral	$40	-84.3%
Feb 18, 2025	Downgrade	BBarclays	Overweight → Equal Weight	$111 → $45	-82.3%
Jan 29, 2025	Downgrade	GGoldman	Buy → Neutral	$99 → $51	-79.9%
Dec 18, 2024	Downgrade	AArgus	Buy → Hold
Dec 10, 2024	Resumed	BBofA Securities	Underperform	$41	-83.9%
Nov 19, 2024	Initiated	BBerenberg	Hold	$42	-83.5%
Nov 18, 2024	Upgrade	HHSBC Securities	Hold → Buy	$58	-77.2%
Nov 15, 2024	Initiated	WWolfe Research	Underperform	$40	-84.3%
Oct 17, 2024	Initiated	BBernstein	Mkt Perform	$55	-78.4%
Sep 13, 2024	Downgrade	OOppenheimer	Outperform → Perform

Today 07:27AM	Modernas CEO eyes Keytruda-eclipsing future for personalised cancer vaccine (Pharmaceutical Technology)
Nov-10-26 07:00AM	Moderna to Present at Upcoming Conference in November 2026 (ACCESSWIRE) -6.75%
Nov-09-26 11:34PM	Why Did U, MRNA, ABNB Stocks Surge To 52-Week Highs Today? (Stocktwits) +5.83%
10:59AM	MRNA support and resistance levels to watch (Investing.com)
Nov-08-26 11:13PM	Why Did MRNA, XERS, VIR Stocks Surge To 52-Week Highs Last Week? (Stocktwits)
01:55PM	Loading…
Nov-06-26 01:55PM	Moderna (MRNA) Stock Hits 52-Week Highs After Q3 Earnings: Buy, Hold, or Sell? (Zacks) +5.27%
01:24PM	Moderna earnings analysis: questions answered and next catalysts (Investing.com)
01:13PM	Moderna Hits Five-Year High On Sales Beat; But The Real Story Is Still Its Cancer Vaccine (Investor's Business Daily)
11:36AM	Earnings live updates: Moderna's COVID vaccine sales drive revenue growth, raised outlook (Yahoo Finance)
10:57AM	Moderna Stock Pops, Taps Multi-Year High After Earnings (Schaeffer's Research)
10:46AM	Moderna Swings To A Profit And Lifts Its Revenue Outlook, But A Stock Up More Than 300% Leaves Little Room For Error (Earnings Whispers)
10:05AM	Moderna shares jump as earnings beat prompts higher 2026 sales outlook (Proactive)
09:29AM	Great Jobs Report. Will It Matter to Market Participants? (Zacks)
08:39AM	5 Things Investors Need to Know About Fridays Markets (Investopedia)
08:16AM	Moderna Shares Jump 10% as Q3 Earnings Beat Forecasts and Revenue Outlook Improves (InvestorsHub)
08:04AM	Loading…
08:04AM	Moderna Stock Is Up 700% on Cancer Vaccine Hype. Earnings Reveal That Covid Still Counts. (Barrons.com)
07:50AM	Moderna shares surge 10% on earnings beat and raised revenue outlook (Investing.com)
07:15AM	Moderna's stock jumps after biotech raises sales outlook (MarketWatch)
06:53AM	Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas (Reuters)
06:51AM	Moderna: Q3 Earnings Snapshot (Associated Press)
06:45AM	Moderna swings to profit as momentum for cancer vaccine builds (Financial Times)
06:45AM	Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates (ACCESSWIRE)
05:35AM	While biotech bets swing on trial data, this dividend payer gained 72% since 2024 (Investing.com)
05:00AM	Moderna earnings due after spectacular rally (MarketWatch)
03:38AM	Stock Market Today: Dow, S&P 500 and Nasdaq set for mixed start after AI carnage led to worst day for techs since 2020; jobs report on tap: live updates (MarketWatch)
02:40AM	Scottish Mortgage NAV total return rises 31.5% as SpaceX listing and Moderna trial success lift performance (Proactive)
Nov-05-26 05:20PM	Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines (ACCESSWIRE) -6.55%
Nov-04-26 09:50AM	Moderna Announces Oral Presentation of mRNA-2808 Clinical Data at 2026 American Society of Hematology Annual Meeting (ACCESSWIRE) +13.11%
Nov-03-26 07:20AM	Pfizer Finds Life Beyond the Pandemic as Earnings Top Estimates (Barrons.com)
Nov-02-26 08:11AM	Tempus AI's Cancer Screen Business Drives Revenue Up 23%, While a Major Purchase Draws Closer (Barrons.com)
01:11AM	Loading…
01:11AM	SLS, IBRX, IOVA End October In Red: Merck And AstraZeneca Earnings Put Cancer Bets And Buyout Hopes In Focus (Stocktwits)
Nov-01-26 10:52PM	Stocktwits Pharma Pulse: Biotech Beats The Broader Market Novo, Pfizer And Moderna Earnings Up Next (Stocktwits)
02:00PM	Jobs, Midterm Elections, Apple, Palantir, McDonald's, Moderna, and More to Watch This Week (Barrons.com)
09:06AM	What To Expect In Markets This Week: AAPL, PLTR, AMD, SMCI, SHOP, Earnings, Jobs Report And More (Stocktwits)
Oct-30-26 12:00PM	This week in charts: ESMOs winners and losers (BioPharma Dive)
11:26AM	Prediction markets herald insider trading risks for private biotechs (Pharmaceutical Technology)
Oct-29-26 02:20PM	Moderna's Tripled Stock Meets A COVID Season Test As Cost Cuts And Flu Launch Plans Face Scrutiny (Earnings Whispers)
08:42AM	Podcast: ESMO26: Major readouts from the 2026 congress (Clinical Trials Arena)
06:30AM	Merck Earnings Blow Past Estimates. Why Wall Street Is Looking Past the Numbers. (Barrons.com)
Oct-28-26 08:51AM	Anthropic IPO on Tap, NVIDIA Updates, & Other Investor Days Shaping Markets (Wall Street Horizon)
Oct-27-26 11:30AM	Scancell cancer vaccine strategy backed by Moderna and Merck trial results (Proactive)
09:19AM	Moderna shares slip as William Blair cuts rating on valuation after rally (Investing.com)
09:00AM	Moderna Has Its Doubters. CEO Bancel Plans to Answer With a Cancer Shot. (Barrons.com)
06:00AM	Oracle, IBM and Intel Have Opted Out of OKX-ICE Stock Tokens, Venues Own Notice Shows (Unchained)
Oct-26-26 06:22PM	Moderna CEO Says Its Cancer Vaccine Isn't a Disappointment, It's a Blockbuster (Barrons.com)
03:17PM	Modernas Rally May Have Run Out of Steam. Heres What to Watch Next (Investopedia)
11:58AM	ESMO 26: A cancer vaccine debate, Roches KRAS progress and Amgens unprecedented data (BioPharma Dive)
10:52AM	Moderna's Cancer Vaccine Rally Hits a Wall. This Other Drugmaker Stole the Show. (Barrons.com)
10:28AM	Moderna Recovers From 10% Dive, But Muted Expectations Haunt Cancer Vaccine (Investor's Business Daily)
09:50AM	The excitement around Moderna's cancer vaccine is cooling. Here's why. (MarketWatch)
07:56AM	Premarket movers: Moderna, Brazil ADRs drop; SpaceX rises (Investing.com)
Oct-25-26 12:01PM	Wells Fargo, Cisco, Intuit Among 6 More Companies Objecting to Tokenized Stocks (decrypt)
Oct-24-26 05:30AM	Moderna Investors Should Brace for More Whiplash (The Wall Street Journal)
Oct-23-26 07:00PM	Moderna's Cancer Vaccine Success Doesn't Live Up to Early Hype (The Wall Street Journal)
04:36PM	Moderna stock extends losses as investors digest melanoma vaccine trial data (Yahoo Finance)
03:02PM	Moderna Executives Sold Shares in Trades Planned Before Vaccine Results (The Wall Street Journal)
02:58PM	The real test for Moderna's cancer vaccine isn't about beating Keytruda. It's keeping cancer from coming back in the long term. (MarketWatch)
02:29PM	Investing.coms stocks of the week (Investing.com)
12:16PM	Merck And Moderna Diverge On Cancer Vaccine Results. Do They Still Have A Viable Drug? (Investor's Business Daily)
12:06PM	Moderna trims losses as investors digest melanoma vaccine trial data (Yahoo Finance)
11:33AM	Merck CEO Plays Down Cost Concerns Over Intismeran We Don't See Cost As A Limit To Access (Stocktwits)
10:06AM	Moderna's Cancer-Vaccine Leak Spurred Panic Selling as Wall Street Wanted a Cure (Barrons.com)
09:49AM	Moderna stock extends decline after leaked data on melanoma vaccine trial (Yahoo Finance)
09:42AM	Stocks extend declines, 10-year Treasury holds below 5%: AlphaCheck (Yahoo Finance)
09:04AM	MRNA Stock: Citi Questions Whether Melanoma Vaccines Benefit Justifies Individualized Tumor Harvesting And Manufacturing (Stocktwits)
08:57AM	Moderna Stock Cools After Cancer Vaccine Data Leak (Schaeffer's Research)
08:54AM	ESMO26: MSD and Moderna drop cancer vaccine trial data early (Clinical Trials Arena)
07:41AM	Stock Market Reels From 2 World-Changing Factors (Barrons.com)
07:24AM	The stock market is splitting in two. Is that signaling trouble ahead, or just a new set of winners? (MarketWatch)
07:00AM	Moderna Named a Top Employer by Science for Twelfth Consecutive Year (ACCESSWIRE)
06:45AM	Moderna, Meta, SpaceX, AT&T, CoreWeave, Sandisk, and More Stocks That Explain Today's Market (Barrons.com)
06:17AM	Deckers trips up after earnings, and other early market movers (MarketWatch)
06:13AM	Nasdaq, Dow, S&P 500 Futures Drop Premarket: NVDA, AMD, META, CRWV, MRNA, WDC, BE In Focus (Stocktwits)
04:24AM	Moderna stock crashes as leaked melanoma data threatens its record August rally (Yahoo Finance)
12:51AM	Moderna Slides Up to 25% as Cancer Vaccine Meets Sky-High Expectations (BeInCrypto)
Oct-22-26 09:28PM	MRNA Stocks Vaccine Rally Cracks As Worst Week In 3 Months Looms Analyst Calls It A Do-Not-Trade Over Wild Swings (Stocktwits) -17.57%
07:44PM	Nasdaq 100 Clocks Worst Day In Four Months As Investors Grow Weary Of Capex, Elevated Debt META, SPCX, BE, MRNA In Focus (Stocktwits)
04:50PM	Moderna Stock Sinks Nearly 20% After Leak of Cancer-Vaccine Data (Investopedia)
04:45PM	MRNA Stock Plunges 18% After Leaked Melanoma Vaccine Data Misses High Hopes (Stocktwits)
04:18PM	Moderna sheds about $24 billion as cancer vaccine data triggers 'sell-the-news' retreat (Reuters)
03:33PM	Details of Moderna's Breakthrough Cancer Vaccine Got Leaked. Its Stock is Plunging. (International Business Times)
03:27PM	Moderna, Merck shares fall on eagerly anticipated cancer vaccine results (BioPharma Dive)
03:21PM	Moderna tumbles to become the worst-performing stock in S&P 500 (MarketWatch)
02:59PM	Merck and Moderna Will Present Results From Landmark Phase 3 INTerpath-001 Trial for Intismeran Autogene Plus KEYTRUDA (pembrolizumab) at ESMO 2026 Presidential Symposium (Business Wire)
02:52PM	Moderna Stock Crashes 25% After Cancer-Vaccine Data Leak (Barrons.com)
02:43PM	Moderna's Shares Plummet After Cancer-Vaccine Data Shared on Social Media (The Wall Street Journal)
02:43PM	Moderna Shares Plunge After Vaccine Data Was Shared on Social Media (The Wall Street Journal)
02:36PM	Moderna Stock Plunges as Apparent Leak Reveals Phase 3 Melanoma Vaccine Data (InvestorsHub)
02:09PM	Moderna Cancer-Vaccine Data Leaks Early, Shares Plummet (The Wall Street Journal)
02:03PM	Moderna's stock tumbles after reported leak of data for cancer vaccine (MarketWatch)
01:50PM	Moderna shares plunge on cancer vaccine data leak (Investing.com)
01:34PM	Moderna Crashes 20% On Reportedly Leaked Cancer Vaccine Data (Investor's Business Daily)
01:24PM	Moderna, Merck Shares Fall After Possible Melanoma Data Leak (Bloomberg)
08:22AM	Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data. (MarketWatch)
12:01AM	Why Did MRNA, CVX, V Stocks Jump To 52-Week Highs Today? (Stocktwits)
Oct-21-26 04:59PM	7 healthcare stocks that stand out as investors pay up for the sector (MarketWatch)
05:30AM	Healthcare Stocks Are Rallying, and Flashing a Warning for the Rest of the Market (The Wall Street Journal)
Oct-20-26 05:14PM	Dow outperforms as Wall Street rises, healthcare stocks lead gains (Reuters) +6.69%
04:35PM	OpenAI acquires startup Orchestra Bio to beef up its biotech business (TechCrunch)
02:41PM	The Healthcare Sector Nears a New High. These Stocks Are Leading the Charge. (Barrons.com)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hoge Stephen	President	Oct 14 '26	Option Exercise	12.21	76,453	933,491	1,638,482	Oct 16 04:09 PM
Hoge Stephen	President	Oct 15 '26	Option Exercise	12.21	76,452	933,479	1,675,710	Oct 16 04:09 PM
Hoge Stephen	President	Oct 15 '26	Sale	220.72	39,145	8,640,084	1,636,565	Oct 16 04:09 PM
Hoge Stephen	President	Oct 14 '26	Sale	213.48	39,224	8,373,453	1,599,258	Oct 16 04:09 PM
Hoge Stephen	Officer	Oct 15 '26	Proposed Sale	220.72	39,145	8,640,033		Oct 15 10:32 AM
Hoge Stephen	Officer	Oct 14 '26	Proposed Sale	213.48	39,224	8,373,519		Oct 14 09:58 AM
Hoge Stephen	President	Sep 14 '26	Option Exercise	12.21	76,453	933,491	1,566,152	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Option Exercise	12.21	76,452	933,479	1,602,310	Sep 16 04:48 PM
Hoge Stephen	President	Sep 15 '26	Sale	146.07	40,281	5,883,846	1,562,029	Sep 16 04:48 PM
Hoge Stephen	President	Sep 14 '26	Sale	144.13	40,294	5,807,574	1,525,858	Sep 16 04:48 PM
Hoge Stephen	Officer	Sep 15 '26	Proposed Sale	146.07	40,281	5,883,709		Sep 15 10:46 AM
Mock James M	Chief Financial Officer	Sep 10 '26	Option Exercise	30.96	19,836	614,123	94,211	Sep 14 04:25 PM
Mock James M	Chief Financial Officer	Sep 10 '26	Sale	134.49	34,836	4,685,094	59,375	Sep 14 04:25 PM
Hoge Stephen	Officer	Sep 14 '26	Proposed Sale	144.13	40,294	5,807,746		Sep 14 02:39 PM
Mock James M	Officer	Sep 10 '26	Proposed Sale	134.49	34,836	4,685,094		Sep 10 10:14 AM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Option Exercise	30.96	3,471	107,462	77,600	Sep 03 04:56 PM
Klinger Shannon Thyme	Chief Legal Officer	Sep 01 '26	Sale	139.95	3,471	485,766	74,129	Sep 03 04:56 PM
Klinger Shannon Thyme	Officer	Sep 01 '26	Proposed Sale	139.95	3,471	485,766		Sep 01 11:22 AM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Option Exercise	19.15	499,246	9,560,561	6,687,037	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 06 '26	Option Exercise	19.15	252,469	4,834,781	6,440,260	Aug 07 04:11 PM
Bancel Stephane	Chief Executive Officer	Aug 05 '26	Sale	57.52	499,246	28,715,011	6,187,791	Aug 07 04:11 PM
Bancel Stephane	Officer	Aug 05 '26	Proposed Sale	58.00	499,246	28,956,268		Aug 05 01:02 PM
Hoge Stephen	President	Jul 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jul 16 04:45 PM
Hoge Stephen	President	Jul 15 '26	Sale	67.60	53,336	3,605,514	1,483,848	Jul 16 04:45 PM
Hoge Stephen	Officer	Jul 15 '26	Proposed Sale	67.60	53,336	3,605,514		Jul 15 10:22 AM
SAGAN PAUL	Former Director	Jun 18 '26	Proposed Sale	64.57	25,770	1,663,875		Jun 18 03:26 PM
Hoge Stephen	President	Jun 15 '26	Option Exercise	19.15	53,336	1,021,384	1,537,184	Jun 17 04:10 PM
Hoge Stephen	President	Jun 15 '26	Sale	51.37	53,336	2,739,870	1,483,848	Jun 17 04:10 PM
Hoge Stephen	Officer	Jun 15 '26	Proposed Sale	51.37	53,336	2,739,870		Jun 15 11:43 AM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Option Exercise	30.96	3,471	107,462	70,939	Jun 08 04:34 PM
Klinger Shannon Thyme	Chief Legal Officer	Jun 04 '26	Sale	50.00	3,471	173,550	67,468	Jun 08 04:34 PM
Klinger Shannon Thyme	Officer	Jun 04 '26	Proposed Sale	50.00	3,471	173,550		Jun 04 01:26 PM
AFEYAN NOUBAR	Director	May 21 '26	Option Exercise	19.15	9,263	177,386	13,187	May 22 07:00 PM
AFEYAN NOUBAR	Director	May 21 '26	Sale	46.84	9,263	433,879	3,924	May 22 07:00 PM
Flagship Pioneering, LLC	Affiliate	May 21 '26	Proposed Sale	46.84	9,263	433,880		May 21 03:06 PM
Hoge Stephen	President	May 15 '26	Option Exercise	19.15	53,336	1,021,384	1,531,333	May 18 04:57 PM
Hoge Stephen	President	May 15 '26	Sale	48.40	53,336	2,581,462	1,477,997	May 18 04:57 PM
Hoge Stephen	Officer	May 15 '26	Proposed Sale	48.40	53,336	2,581,462		May 15 09:47 AM
SAGAN PAUL	Former Director	May 08 '26	Proposed Sale	54.48	36,759	2,002,787		May 08 11:24 AM
Hussain Abbas	Director	May 01 '26	Sale	46.63	5,682	264,952	12,066	May 04 05:25 PM
Hussain Abbas	Director	May 01 '26	Proposed Sale	46.63	5,682	264,952		May 01 11:44 AM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Option Exercise	30.96	13,885	429,880	73,574	Mar 03 04:10 PM
Klinger Shannon Thyme	Chief Legal Officer	Mar 02 '26	Sale	52.29	13,885	726,047	59,689	Mar 03 04:10 PM
Klinger Shannon Thyme	Officer	Mar 02 '26	Proposed Sale	52.29	13,885	726,047		Mar 02 09:56 AM
Hoge Stephen	President	Feb 23 '26	Option Exercise	19.15	160,009	3,064,172	1,617,436	Feb 25 04:49 PM
Hoge Stephen	President	Feb 23 '26	Sale	48.84	160,009	7,814,840	1,457,427	Feb 25 04:49 PM
Hoge Stephen	Officer	Feb 23 '26	Proposed Sale	48.84	160,009	7,814,840		Feb 23 10:26 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Option Exercise	10.90	23,853	259,998	27,777	Dec 15 09:00 AM
AFEYAN NOUBAR	Director	Dec 11 '25	Sale	29.48	23,853	703,306	3,924	Dec 15 09:00 AM
Bancel Stephane	Chief Executive Officer	Dec 11 '25	Option Exercise	10.90	688,073	7,499,996	6,181,970	Dec 15 08:59 AM
Flagship Pioneering Inc.	Affiliate	Dec 11 '25	Proposed Sale	29.49	23,853	703,306		Dec 11 04:30 PM
Hussain Abbas	Director	Dec 09 '25	Sale	27.60	504	13,910	1,515	Dec 11 04:16 PM
Hussain Abbas	Director	Dec 09 '25	Proposed Sale	27.60	504	13,910		Dec 09 10:26 AM

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

CEO & DirectorMr. Stephane Bancel M.B.A.

PresidentDr. Stephen Hoge M.D.

Chief Financial OfficerMr. James M. Mock

Chief Legal Officer & Corporate SecretaryMs. Shannon Thyme Klinger J.D.

Chief Operating OfficerMr. Juan Andres

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

All the Features.Half the Price.

MRNA

Moderna Inc

Upgrade your Finviz experience

All the Features.
Half the Price.